VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XENEXenon Pharmaceuticals Inc.
$59.74$4.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksXENEPrice History

XENE logoXenon Pharmaceuticals Inc. (XENE) Stock Price History

Historical prices from 2014 to 2026

$59.74+2.96  (+5.21%)close Jun 26
Returns
1M
+10.7%
3M
+7.6%
YTD
+34.3%
1Y
+85.5%
3Y
+15.2%
5Y
+27.0%
ATH$63.95Mar 2026-6.6%
ATL$2.10Nov 2017pre-split
Avg Vol (50D)1.1M/ day
52-Week Range$30.00 — $63.95
LowCurrent: $59.74High

Loading 10-year price history...

XENE Historical Performance

1 YearTotal Return
+72.8%
Price: +85.5%
3 YearsTotal Return
+42.4%
CAGR: +12.5%
Price: +53.1%
5 YearsTotal Return
+204.4%
CAGR: +24.9%
Price: +230.2%
YTD
+34.3%

XENE Annual Returns

Year-by-year price performance · 2014–2026

Best+119.1%2018
Worst-63.9%2017
Up years8/13
2014+88.1%
2015-57.0%
2016-3.3%
2017-63.9%
2018+119.1%
2019+96.3%
2020+12.1%
2021+111.9%
2022+24.8%
2023+23.6%
2024-12.7%
2025+11.6%
2026-2.8%
2014 annual price return
+88.1%
2015 annual price return
-57.0%
2016 annual price return
-3.3%
2017 annual price return
-63.9%
2018 annual price return
+119.1%
2019 annual price return
+96.3%
2020 annual price return
+12.1%
2021 annual price return
+111.9%
2022 annual price return
+24.8%
2023 annual price return
+23.6%
2024 annual price return
-12.7%
2025 annual price return
+11.6%
2026 annual price return
-2.8%
LessMore
Alpha vs S&P 500
1Y+51.9%
3Y-8.4%
5Y+13.3%

Price returns only.

Download Historical Data

2,927 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

XENE Stock Price Trajectory (2014–2026)

As of June 28, 2026, Xenon Pharmaceuticals Inc. (XENE) trades at $59.74, representing a +85.5% return over the past year. The stock has delivered a +204.4% total return over five years (+27.0% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $63.95 on March 10, 2026. From this peak, XENE has corrected -6.6%, currently trading 27% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers PRAX (+644.3% 1Y), ACAD (+14.0% 1Y), and PTCT (+70.4% 1Y), XENE has underperformed the peer group average. Compare XENE vs PRAX →

XENE Historical Price Data · from 2014

Rows 1–50 of 2,927
Date Open High Low Close Volume Change %
2026-06-2656.9760.3256.8059.740+5.21%
2026-06-2555.3957.1455.2856.781.07M+2.16%
2026-06-2454.8056.5154.6155.581.43M+1.78%
2026-06-2355.1655.4754.1254.611.50M-0.33%
2026-06-2253.1255.5952.9154.791.79M+3.55%
2026-06-1854.0954.7352.5352.912.37M-0.55%
2026-06-1752.4553.8352.1153.201.07M+2.33%
2026-06-1652.3052.6751.5451.99709K-0.78%
2026-06-1552.1452.7451.6752.401.15M+0.58%
2026-06-1252.0253.0452.0152.10691K-0.17%
2026-06-1152.6252.6251.1152.191.70M+1.66%
2026-06-1052.7553.7651.3051.341.23M-2.75%
2026-06-0952.1452.8751.3352.791.42M+3.09%
2026-06-0851.9252.5550.9251.211.18M-1.01%
2026-06-0553.1653.5851.5351.731.68M-2.38%
2026-06-0453.5054.6152.9952.991.36M-0.88%
2026-06-0352.5253.8652.3053.461.70M+2.22%
2026-06-0253.4154.3952.2352.301.88M-2.08%
2026-06-0154.4355.2453.1053.411.26M-2.41%
2026-05-2954.7655.3854.3754.731.33M-0.11%
2026-05-2853.6155.5453.2454.792.30M+1.65%
2026-05-2754.0054.5053.3753.902.20M-0.15%
2026-05-2654.2154.9953.8453.981.69M-0.35%
2026-05-2254.1655.2454.1454.17922K+0.09%
2026-05-2154.0154.8853.6354.121.13M-1.02%
2026-05-2054.2855.8054.2854.681.00M+1.17%
2026-05-1953.4154.1352.8554.05843K+0.63%
2026-05-1854.6154.8653.1653.71655K-1.25%
2026-05-1555.6455.7354.3154.39591K-2.88%
2026-05-1456.6956.8055.0356.001.33M+0.21%
2026-05-1355.1055.8854.6955.881.03M+1.60%
2026-05-1256.3156.3154.7955.00772K-1.40%
2026-05-1155.9957.1655.3155.78698K-1.17%
2026-05-0856.1357.4755.7356.44887K+0.79%
2026-05-0757.6057.6055.9556.00551K-4.36%
2026-05-0657.6458.8757.4958.55704K+1.50%
2026-05-0558.0458.5356.9057.691.21M+0.51%
2026-05-0455.8658.4955.8657.40398K+2.26%
2026-05-0156.7457.8955.9856.131.78M+0.16%
2026-04-3055.7056.8655.2456.041.07M+0.52%
2026-04-2953.8956.9153.8055.751.70M+2.24%
2026-04-2854.8555.5353.3054.53718K+0.50%
2026-04-2755.0356.1154.0254.26678K-1.77%
2026-04-2455.4255.5654.4055.24533K-0.25%
2026-04-2356.6557.5155.2355.38607K-2.24%
2026-04-2256.7357.9056.2556.65703K+0.44%
2026-04-2156.4856.9455.7756.40624K-1.21%
2026-04-2059.2359.6856.9057.091.09M-4.37%
2026-04-1759.4759.8358.6559.70844K+2.17%
2026-04-1658.6358.8857.8258.43957K-0.76%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XENE — Frequently Asked Questions

Quick answers to the most common questions about buying XENE stock.

How has XENE stock performed recently?

XENE returned +85.5% over the past year, beating its 5-year annualized CAGR of +27.0%. The stock trades above its 200-day moving average, confirming the uptrend.

What is XENE's all-time high price?

Xenon Pharmaceuticals Inc. reached $63.95 on 2026-03-10. The 52-week high is $63.95. Current 1-year return of +85.5% places the stock closer to historical peaks.

Where can I download XENE historical price data?

This page provides XENE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

489 data points · sampled from 2,927